Peptic ulcer disease: Difference between revisions
(Added quadruple therapy) |
No edit summary |
||
| Line 5: | Line 5: | ||
**NSAIDs inhibit prostaglandin synthesis (decreases mucus and bicarb production) | **NSAIDs inhibit prostaglandin synthesis (decreases mucus and bicarb production) | ||
== | ==Clinical Features== | ||
*Burning epigastric pain | *Burning epigastric pain | ||
**May awaken pt at night (gastric contents empty) | **May awaken pt at night (gastric contents empty) | ||
| Line 13: | Line 13: | ||
**Postprandial pain, food intolerance, nausea, retrosternal pain, belching | **Postprandial pain, food intolerance, nausea, retrosternal pain, belching | ||
==Work-Up== | ==Differential Diagnosis== | ||
{{Template:Abdominal Pain DDX Epigastric}} | |||
==Diagnosis== | |||
===Work-Up=== | |||
*CBC (r/o anemia) | *CBC (r/o anemia) | ||
*LFTs | *LFTs | ||
*Lipase | *Lipase | ||
* | *Consider [[acute abdominal series]] if concern for perforation (>50 years old; concerning abdominal exam) | ||
* | *Conside [[RUQ US]] | ||
* | *Consider [[ECG]] | ||
* | *Consider troponin | ||
== | ===Evaluation=== | ||
*Diagnosis not typically definitively made in ED (requires endoscopy or H pilori test) | |||
*Depending on clinical certainty can consider initial empiric treatment | |||
==Treatment== | ==Treatment== | ||
*Stop | *Stop [[NSAIDs]] and [[ETOH]] | ||
*[[PPI]] | |||
* | |||
**Generally heal ulcers faster than H2 blockers | **Generally heal ulcers faster than H2 blockers | ||
**[[Omeprazole]] 20-40mg QD | **[[Omeprazole]] 20-40mg QD | ||
| Line 36: | Line 38: | ||
**[[Famotidine]] 20-40mg QD | **[[Famotidine]] 20-40mg QD | ||
**[[Ranitidine]] 75-150mg BID | **[[Ranitidine]] 75-150mg BID | ||
*Eradicate H. pylori if identified in symptomatic patient | |||
**Triple Therapy: PPI + [[clarithromycin]] 500mg BID + ([[amoxicillin]] 1g or [[metronidazole]] 500mg) BID x 10-14d | |||
**Quadruple Therapy: PPI + bismuth subsalicylate 524 mg QID + [[metronidazole]] 250 mg QID and [[tetracycline]] 500 mg QID x 10-14d | |||
==Disposition== | ==Disposition== | ||
| Line 58: | Line 63: | ||
**Most commonly occurs in anterior wall of duodenum. | **Most commonly occurs in anterior wall of duodenum. | ||
**Abrupt onset of severe epigastric pain | **Abrupt onset of severe epigastric pain | ||
** | **Patients may not have history of ulcer-like symptoms | ||
**Consult surgery | **Consult surgery | ||
*Obstruction | *Obstruction | ||
| Line 68: | Line 73: | ||
*[[Epigastric abdominal pain]] | *[[Epigastric abdominal pain]] | ||
== | ==References== | ||
[[Category:GI]] | [[Category:GI]] | ||
Revision as of 21:08, 27 October 2015
Background
- Recurrent ulcerations in the stomach and proximal duodenum
- Majority of cases related to H. pylori or NSAID use
- H. pylori found in 30-40% of U.S. population
- NSAIDs inhibit prostaglandin synthesis (decreases mucus and bicarb production)
Clinical Features
- Burning epigastric pain
- May awaken pt at night (gastric contents empty)
- Abrupt onset of severe pain may indicate perforation
- Abrupt onset of back pain may indicate penetration into the pancreas
- The following symptoms are NOT associated w/ PUD:
- Postprandial pain, food intolerance, nausea, retrosternal pain, belching
Differential Diagnosis
Epigastric Pain
- Gastroesophageal reflux disease (GERD)
- Peptic ulcer disease with or without perforation
- Gastritis
- Pancreatitis
- Gallbladder disease
- Myocardial Ischemia
- Splenic Infarctionenlargement/rupture/aneurysm
- Pericarditis/Myocarditis
- Aortic dissection
- Hepatitis
- Pyelonephritis
- Pneumonia
- Pyogenic liver abscess
- Fitz-Hugh-Curtis Syndrome
- Hepatomegaly due to CHF
- Bowel obstruction
- SMA syndrome
- Pulmonary embolism
- Bezoar
- Ingested foreign body
Diagnosis
Work-Up
- CBC (r/o anemia)
- LFTs
- Lipase
- Consider acute abdominal series if concern for perforation (>50 years old; concerning abdominal exam)
- Conside RUQ US
- Consider ECG
- Consider troponin
Evaluation
- Diagnosis not typically definitively made in ED (requires endoscopy or H pilori test)
- Depending on clinical certainty can consider initial empiric treatment
Treatment
- Stop NSAIDs and ETOH
- PPI
- Generally heal ulcers faster than H2 blockers
- Omeprazole 20-40mg QD
- H2 Blockers
- Famotidine 20-40mg QD
- Ranitidine 75-150mg BID
- Eradicate H. pylori if identified in symptomatic patient
- Triple Therapy: PPI + clarithromycin 500mg BID + (amoxicillin 1g or metronidazole 500mg) BID x 10-14d
- Quadruple Therapy: PPI + bismuth subsalicylate 524 mg QID + metronidazole 250 mg QID and tetracycline 500 mg QID x 10-14d
Disposition
- Normally outpatient management, unless complication (see below)
Red Flags
Any of the following suggest need for endoscopy referral:
- Age >55yr
- Unexplained weight loss
- Early satiety
- Persistent vomiting
- Dysphagia
- Anemia or GI bleeding
- Abdominal mass
- Persistent anorexia
- Jaundice
Complications
- Hemorrhage
- Perforation
- Most commonly occurs in anterior wall of duodenum.
- Abrupt onset of severe epigastric pain
- Patients may not have history of ulcer-like symptoms
- Consult surgery
- Obstruction
- Occurs due to:
- Scarring of gastric outlet
- Edema due to active ulcer
- Occurs due to:
